Vertical sleeve gastrectomy
3 papers study it4 findings
- 2 independent labs in 4 countries
- Funders: AstraZeneca and others
- Human trial1
- Animals2
Outcomes
4Immune response
upin mice1
1 study
Immune response
upin mice1
Vertical sleeve gastrectomy improves immune response in mice.
“VSG and CR regimens exerted both similar and unique effects, as assessed using multiomics approaches, in reversing obesity-associated transcript, epigenetics, secretome, and microbiota changes and restoring antitumor immunity.”
Animalsin a murine model of obesity-driven TNBC
JCI insightSep 12, 2023
Tumor growth
downin mice1
1 study
Tumor growth
downin mice1
Vertical sleeve gastrectomy decreases tumor growth in mice.
“Each intervention generated weight and fat loss and suppressed tumor growth relative to obese mice (greatest suppression with CR).”
Animalsrelative to obese mice
JCI insightSep 12, 2023
Glucose excursions
downin mice1
1 study
Glucose excursions
downin mice1
Vertical sleeve gastrectomy decreases glucose excursions in mice (lowered by ∼30% in wild-type mice but by ∼20% in SGLT2-null animals).
“with glucose excursions following intraperitoneal injection lowered by ∼30% in wild-type mice but by ∼20% in SGLT2-null animals.”
Animalsfollowing intraperitoneal injection in wild-type mice
Vertical Sleeve Gastrectomy Lowers SGLT2/Slc5a2 Expression in the Mouse Kidney
DiabetesMay 20, 2022
SLC5A2
downin mice1
1 study
SLC5A2
downin mice1
Vertical sleeve gastrectomy decreases SLC5A2 in mice.
“the expression of sodium-glucose cotransporter 2 (SGLT2/Slc5a2) is reduced in the kidney of lean and obese mice following vertical sleeve gastrectomy (VSG).”
Animalsin lean and obese micekidney
Vertical Sleeve Gastrectomy Lowers SGLT2/Slc5a2 Expression in the Mouse Kidney
DiabetesMay 20, 2022